Health-State Utility Values in Patients Affected by Flaccid and Non-Flaccid Facial Paralysis

Area of Science:

• Health Economics
• Quality of Life Research
• Facial Nerve Disorders

Background:

• Facial paralysis significantly impacts patient quality of life.
• Health-state utility values (HSUVs) are crucial for cost-effectiveness analyses.
• Limited data exists on HSUVs in facial paralysis patients.

Purpose of the Study:

• To measure HSUVs in patients with facial paralysis before and after treatment.
• To compare HSUVs in facial paralysis with other chronic diseases.
• To establish a baseline for cost-effectiveness studies of facial paralysis treatments.

Main Methods:

• Retrospective chart review at a tertiary medical center.
• Inclusion of adult patients with flaccid and non-flaccid facial paralysis.
• Utilized the Short-Form 6D health index to derive HSUVs at baseline and post-treatment.

Main Results:

• Mean baseline HSUV was 0.73 (±0.14), significantly lower than US population norms.
• Baseline HSUVs correlated with disease-specific quality of life (Facial Clinimetric Evaluation Scale).
• Overall treatment showed a mean HSUV improvement of 0.03, with slightly greater gains in the flaccid group.

Conclusions:

• Facial paralysis patients report significantly diminished HSUVs.
• Treatment interventions demonstrate a positive impact on HSUVs.
• Findings support future cost-effectiveness evaluations for facial paralysis management.